Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
NCT00320398
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
114
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombosis, Venous
Interventions
DRUG:
Fondaparinux
Sponsor
GlaxoSmithKline